Related Experiment Video
Updated: Dec 27, 2025

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
ROS-responsive drug delivery systems for biomedical applications.
1Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103 Wenhua Road, Shenyang 110016, China.
Stimuli-responsive drug delivery systems (DDSs) offer targeted treatment by releasing drugs in response to specific triggers. ROS-responsive DDSs are promising for diseases like cancer, releasing medication only where needed.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Background:
- Stimuli-responsive drug delivery systems (DDSs) enhance treatment efficacy and reduce side effects by enabling site-specific drug release.
- Reactive oxygen species (ROS) are key regulators of cellular processes, but their overproduction causes oxidative stress implicated in diseases like cancer, inflammation, and atherosclerosis.
Purpose of the Study:
- To review the latest advancements and novel designs in ROS-responsive DDSs.
- To discuss the design principles and biomedical applications of these targeted delivery systems.
Main Methods:
- Literature review of recent research on ROS-responsive DDSs.
- Analysis of different DDS design strategies and release mechanisms.
- Examination of applications in various biomedical fields.
Main Results:
- ROS-responsive DDSs are designed to release therapeutic agents in response to elevated ROS levels.
- Key release mechanisms include ROS-induced changes in carrier solubility, carrier cleavage, or prodrug linker cleavage.
- These systems show significant potential for targeted therapy in ROS-associated diseases.
Conclusions:
- ROS-responsive DDSs represent a significant advancement in targeted drug delivery.
- Their ability to selectively release payloads in ROS-overproducing cells offers a promising strategy for treating diseases such as cancer and inflammation.
- Further research into novel designs and applications will continue to expand their biomedical utility.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Bioavailability Enhancement: Drug Permeability Enhancement
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Drug Delivery: Enteral Route

